Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1995Current Opinion in Structural BiologyOpen Access

Glycosylation inhibitors in biology and medicine

View Full Paper
Ask AI
Bookmark
Share

Authors

GJGary S. JacobCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gary S. Jacob (1995) studied this question.

synapsesocial.com/papers/6a9280646a4f73282e18276dhttps://doi.org/10.1016/0959-440x(95)80051-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term Efficacy and Safety of Acarbose in the Treatment of Obese Subjects With Non—Insulin-Dependent Diabetes Mellitus1994 · 88 citations
  2. 2Inhibition of glucose trimming by castanospermine results in rapid degradation of unassembled major histocompatibility complex class I molecules.1993 · 87 citations
  3. 3β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis1987 · 946 citations
  4. 4Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAb1994 · 12 citations
  5. 5Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control.1994 · 847 citations